Literature DB >> 11384745

The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting.

H Maeda1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384745     DOI: 10.1016/s0065-2571(00)00013-3

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


× No keyword cloud information.
  544 in total

Review 1.  Nanoparticle mediated non-covalent drug delivery.

Authors:  Tennyson Doane; Clemens Burda
Journal:  Adv Drug Deliv Rev       Date:  2012-06-01       Impact factor: 15.470

2.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.

Authors:  Azadeh Kheirolomoom; Lisa M Mahakian; Chun-Yen Lai; Heather A Lindfors; Jai Woong Seo; Eric E Paoli; Katherine D Watson; Eric M Haynam; Elizabeth S Ingham; Li Xing; R Holland Cheng; Alexander D Borowsky; Robert D Cardiff; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-12-06       Impact factor: 4.939

3.  Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

Authors:  Juntao Luo; Kai Xiao; Yuanpei Li; Joyce S Lee; Lifang Shi; Yih-Horng Tan; Li Xing; R Holland Cheng; Gang-Yu Liu; Kit S Lam
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

Review 4.  Molecular-targeted nanotherapies in cancer: enabling treatment specificity.

Authors:  Elvin Blanco; Angela Hsiao; Guillermo U Ruiz-Esparza; Matthew G Landry; Funda Meric-Bernstam; Mauro Ferrari
Journal:  Mol Oncol       Date:  2011-10-25       Impact factor: 6.603

Review 5.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

6.  Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.

Authors:  Xuelei Yin; Yingying Chi; Chuanyou Guo; Shuaishuai Feng; Jinhu Liu; Kaoxiang Sun; Zimei Wu
Journal:  Pharm Res       Date:  2017-07-19       Impact factor: 4.200

7.  Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

Authors:  Haifa Shen; Cristian Rodriguez-Aguayo; Rong Xu; Vianey Gonzalez-Villasana; Junhua Mai; Yi Huang; Guodong Zhang; Xiaojing Guo; Litao Bai; Guoting Qin; Xiaoyong Deng; Qingpo Li; Donald R Erm; Burcu Aslan; Xuewu Liu; Jason Sakamoto; Arturo Chavez-Reyes; Hee-Dong Han; Anil K Sood; Mauro Ferrari; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

Review 8.  Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.

Authors:  Avinash Gothwal; Iliyas Khan; Umesh Gupta
Journal:  Pharm Res       Date:  2015-09-17       Impact factor: 4.200

9.  Design and evaluation of a PEGylated lipopeptide equipped with drug-interactive motifs as an improved drug carrier.

Authors:  Peng Zhang; Jianqin Lu; Yixian Huang; Wenchen Zhao; Yifei Zhang; Xiaolan Zhang; Jiang Li; Raman Venkataramanan; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2013-11-27       Impact factor: 4.009

10.  Perspectives on clinical translation of smart nanotherapeutics.

Authors:  Joyce Lee; Kit S Lam
Journal:  Ther Deliv       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.